Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Adžić, Gordan; Prejac, Juraj; Pleština, Stjepko
Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report // Frontiers in oncology, XIII (2023), 01-04. doi: 10.3389/fonc.2023.1260989
Prejac, Juraj; Omrčen, Tomislav; Radić, Jasna; Vrdoljak, Eduard; Frobe, Ana; Pleština, Stjepko
Predicting Trifluridine/Tipiracil Treatment in Refractory Metastatic Colorectal Cancer Patients: A Multicenter Exploratory Analysis // Oncology, (2023), doi: 10.1159/000533567
Librenjak, Nikša ; Prejac, Juraj ; Kekez, Domina ; Goršić, Irma ; Pleština, Stjepko
The effect of duration of induction therapy on survival in patients receiving maintenance therapy in the first line for metastatic colorectal cancer: A single-center retrospective analysis // Annals of oncology / André, F. (ur.). 2022. str. S330-S330 doi: 10.1016/j.annonc.2022.04.320
Prejac, Juraj ; Omrčen, Tomislav ; Radić, Jasna ; Vrdoljak, Eduard ; Fröbe, Ana ; Pleština, Stjepko
A multicenter exploratory analysis of the possible predictive factors for trifluridine/tipiracil in refractory metastatic colorectal cancer // Annals of oncology / André, F. (ur.). 2022. str. S316-S316 doi: 10.1016/j.annonc.2022.04.276
Prejac, Juraj ; Tomek Hamzić, Dora ; Librenjak, Nikša ; Goršić, Irma ; Kekez, Domina MD ; Pleština, Stjepko
The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first- line metastatic pancreatic cancer treatment: A real-world evidence // Medicine, 101 (2022), 39; e30566, 7. doi: 10.1097/MD.0000000000030566
Prejac, Juraj ; Kekez, Domina ; Belev, Borislav ; Prejac, Marija ; Pleština, Stjepko
Frequency of Body Weight Loss is an Independent Prognostic Factor of First-Line Treatment Outcomes in Metastatic Colorectal Cancer // Nutrition and cancer, 74 (2022), 2; 520-526. doi: 10.1080/01635581.2021.1900300
Prejac Juraj, Omrčen Tomislav, Radić Jasna, Froebe Ana, Vrdoljak Eduard, Pleština Stjepko
Possible predictive factors for the effectiveness of trifluridine/tipiracil in refractory metastatic colorectal cancer. A multicenter exploratory analysis // Libri oncologici : Croatian journal of oncology. 2021. str. 117-118
Prejac, Juraj ; Dedić Plavetić, Natalija ; Gotovac Jerčić, Kristina ; Borovečki, Fran
A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor // World journal of surgical oncology, 19 (2021), 1; 254, 6. doi: 10.1186/s12957-021-02370-8
Momčilović, Berislav ; Prejac, Juraj ; Mimica, Ninoslav
Assessing human molybdenum nutritional status by analyzing frequency distribution properties in the hair and whole blood with a median derivatives bioassay // Current developments in nutrition, 4 (2020), Suppl 2; 1455, 1. doi: 10.1093/cdn/nzaa061_083
Prejac, Juraj ; Kekez, Domina ; Pleština, Stjepko
Treatment outcomes of trifluridine/tipiracil therapy in refractory metastatic colorectal cancer: A single-centre observational study // Annals of oncology. 2020. str. S154-S154 doi: 10.1016/j.annonc.2020.04.277